Changes in coronary sinus pH during dipyridamole stress in patients with hypertrophic cardiomyopathy.
Open Access
- 1 February 1996
- Vol. 75 (2) , 179-183
- https://doi.org/10.1136/hrt.75.2.179
Abstract
OBJECTIVES: The presence of angina pectoris and myocardial scarring in patients with hypertrophic cardiomyopathy (HCM) suggests that myocardial ischemia is a factor in the pathophysiology of the disease. The clinical evaluation of ischaemia is problematic in HCM as baseline electrocardiographic abnormalities are frequent and thallium-201 perfusion abnormalities correlate poorly with anginal symptoms. Coronary sinus pH measurement using a catheter mounted pH electrode is a validated sensitive technique for the detection of myocardial ischaemia. METHODS AND RESULTS: 11 patients with HCM and chest pain (eight men; mean (SD) (range) age 36 (11) (19-53) years) and six controls (two men; mean (SD) (range) age 49 (11) (31-62) years) with atypical pain and normal coronary angiograms were studied. Eight patients with HCM had baseline ST segment depression of > or = 1 mm and four had reversible perfusion defects during stress 201TI scintigraphy. A catheter mounted hydrogen ion sensitive electrode was introduced into the coronary sinus and pH monitored continuously during dipyridamole infusion (0.56 mg/kg over four min). The maximal change in coronary sinus pH during dipyridamole stress was greater in patients with HCM than in controls (0.082 (0.083) (0 to -0.275) v 0.005 (0.006) (0 to -0.012), P = 0.02). In six patients (four men; mean (SD) (range) age 29 (9) (19-40 years) the development of chest pain was associated with a gradual decline in coronary sinus pH (mean 0.123 (0.089)), peaking at 442 (106) s. There were no relations among left ventricular dimensions, maximal wall thickness, and maximum pH change. In patients with HCM there was a correlation between maximum pH change and maximum heart rate during dipyridamole infusion (r = 0.70, P = 0.02). CONCLUSION: This study provides further evidence that chest pain in patients with HCM is caused by myocardial ischaemia. The role of myocardial ischaemia in the pathophysiology of the disease remains to be determined but coronary sinus pH monitoring provides a method for quantifying and prospectively assessing its effects on clinical presentation and prognosis.Keywords
This publication has 25 references indexed in Scilit:
- Significance of positive or negative thallium-201 scintigraphy in hypertrophic cardiomyopathyThe American Journal of Cardiology, 1989
- Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures.Circulation, 1985
- Pathophysiology of chest pain in patients with cardiomyopathies and normal coronary arteries.Circulation, 1982
- Myocardial lactate metabolism: evidence of lactate release during net chemical extraction in man.Circulation, 1981
- Prognosis in hypertrophic cardiomyopathy: Role of age and clinical, electrocardiographic and hemodynamic featuresThe American Journal of Cardiology, 1981
- Myocardial lactate extraction: multi-determined metabolic function.Circulation, 1980
- Idiopathic hypertrophic subaortic stenosis: Evaluation of anginal symptoms with thallium-201 myocardial imagingThe American Journal of Cardiology, 1979
- Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologie coronary vasodilatationThe American Journal of Cardiology, 1978
- A Critical Appraisal of the Electrocardiographic Criteria for the Diagnosis of Left Ventricular HypertrophyCirculation, 1969
- Idiopathic Hypertrophic Subaortic StenosisCirculation, 1968